These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 12124866

  • 1. Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial.
    Petri MA, Lahita RG, Van Vollenhoven RF, Merrill JT, Schiff M, Ginzler EM, Strand V, Kunz A, Gorelick KJ, Schwartz KE, GL601 Study Group.
    Arthritis Rheum; 2002 Jul; 46(7):1820-9. PubMed ID: 12124866
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: a multicenter randomized, double-blind, placebo-controlled trial.
    Chang DM, Lan JL, Lin HY, Luo SF.
    Arthritis Rheum; 2002 Nov; 46(11):2924-7. PubMed ID: 12428233
    [Abstract] [Full Text] [Related]

  • 4. Effects of prasterone on bone mineral density in women with systemic lupus erythematosus receiving chronic glucocorticoid therapy.
    Mease PJ, Ginzler EM, Gluck OS, Schiff M, Goldman A, Greenwald M, Cohen S, Egan R, Quarles BJ, Schwartz KE.
    J Rheumatol; 2005 Apr; 32(4):616-21. PubMed ID: 15801015
    [Abstract] [Full Text] [Related]

  • 5. Effects of prasterone on bone mineral density in women with active systemic lupus erythematosus receiving chronic glucocorticoid therapy.
    Sánchez-Guerrero J, Fragoso-Loyo HE, Neuwelt CM, Wallace DJ, Ginzler EM, Sherrer YR, McIlwain HH, Freeman PG, Aranow C, Petri MA, Deodhar AA, Blanton E, Manzi S, Kavanaugh A, Lisse JR, Ramsey-Goldman R, McKay JD, Kivitz AJ, Mease PJ, Winkler AE, Kahl LE, Lee AH, Furie RA, Strand CV, Lou L, Ahmed M, Quarles B, Schwartz KE.
    J Rheumatol; 2008 Aug; 35(8):1567-75. PubMed ID: 18634158
    [Abstract] [Full Text] [Related]

  • 6. Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus.
    Carneiro JR, Sato EI.
    J Rheumatol; 1999 Jun; 26(6):1275-9. PubMed ID: 10381042
    [Abstract] [Full Text] [Related]

  • 7. Treatment of systemic lupus erythematosus with dehydroepiandrosterone: 50 patients treated up to 12 months.
    van Vollenhoven RF, Morabito LM, Engleman EG, McGuire JL.
    J Rheumatol; 1998 Feb; 25(2):285-9. PubMed ID: 9489820
    [Abstract] [Full Text] [Related]

  • 8. Dehydroepiandrosterone suppresses interleukin 10 synthesis in women with systemic lupus erythematosus.
    Chang DM, Chu SJ, Chen HC, Kuo SY, Lai JH.
    Ann Rheum Dis; 2004 Dec; 63(12):1623-6. PubMed ID: 15547086
    [Abstract] [Full Text] [Related]

  • 9. The effect of moderate-dose corticosteroids in preventing severe flares in patients with serologically active, but clinically stable, systemic lupus erythematosus: findings of a prospective, randomized, double-blind, placebo-controlled trial.
    Tseng CE, Buyon JP, Kim M, Belmont HM, Mackay M, Diamond B, Marder G, Rosenthal P, Haines K, Ilie V, Abramson SB.
    Arthritis Rheum; 2006 Nov; 54(11):3623-32. PubMed ID: 17075807
    [Abstract] [Full Text] [Related]

  • 10. Effects of dehydroepiandrosterone supplement on health-related quality of life in glucocorticoid treated female patients with systemic lupus erythematosus.
    Nordmark G, Bengtsson C, Larsson A, Karlsson FA, Sturfelt G, Rönnblom L.
    Autoimmunity; 2005 Nov; 38(7):531-40. PubMed ID: 16373258
    [Abstract] [Full Text] [Related]

  • 11. Steroid-sparing effects of methotrexate in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial.
    Fortin PR, Abrahamowicz M, Ferland D, Lacaille D, Smith CD, Zummer M, Canadian Network For Improved Outcomes in Systemic Lupus.
    Arthritis Rheum; 2008 Dec 15; 59(12):1796-804. PubMed ID: 19035431
    [Abstract] [Full Text] [Related]

  • 12. Dehydroepiandrosterone in systemic lupus erythematosus: relationship between dosage, serum levels, and clinical response.
    Barry NN, McGuire JL, van Vollenhoven RF.
    J Rheumatol; 1998 Dec 15; 25(12):2352-6. PubMed ID: 9858429
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial.
    Ogrendik M.
    Clin Ther; 2009 Aug 15; 31(8):1754-64. PubMed ID: 19808134
    [Abstract] [Full Text] [Related]

  • 14. Effects of dehydroepiandrosterone on fatigue and well-being in women with quiescent systemic lupus erythematosus: a randomised controlled trial.
    Hartkamp A, Geenen R, Godaert GL, Bijl M, Bijlsma JW, Derksen RH.
    Ann Rheum Dis; 2010 Jun 15; 69(6):1144-7. PubMed ID: 19854713
    [Abstract] [Full Text] [Related]

  • 15. A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus.
    van Vollenhoven RF, Park JL, Genovese MC, West JP, McGuire JL.
    Lupus; 1999 Jun 15; 8(3):181-7. PubMed ID: 10342710
    [Abstract] [Full Text] [Related]

  • 16. Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti-CD154: a randomized, double-blind, placebo-controlled trial.
    Kalunian KC, Davis JC, Merrill JT, Totoritis MC, Wofsy D, IDEC-131 Lupus Study Group.
    Arthritis Rheum; 2002 Dec 15; 46(12):3251-8. PubMed ID: 12483729
    [Abstract] [Full Text] [Related]

  • 17. Steroid injection for osteoarthritis of the hip: a randomized, double-blind, placebo-controlled trial.
    Lambert RG, Hutchings EJ, Grace MG, Jhangri GS, Conner-Spady B, Maksymowych WP.
    Arthritis Rheum; 2007 Jul 15; 56(7):2278-87. PubMed ID: 17599747
    [Abstract] [Full Text] [Related]

  • 18. Menopause hormonal therapy in women with systemic lupus erythematosus.
    Sánchez-Guerrero J, González-Pérez M, Durand-Carbajal M, Lara-Reyes P, Jiménez-Santana L, Romero-Díaz J, Cravioto MD.
    Arthritis Rheum; 2007 Sep 15; 56(9):3070-9. PubMed ID: 17763408
    [Abstract] [Full Text] [Related]

  • 19. Tibolone in postmenopausal women with systemic lupus erythematosus: a pilot study.
    Vieira CS, Pereira FV, de Sá MF, Paulo LJ, Martins WP, Ferriani RA.
    Maturitas; 2009 Mar 20; 62(3):311-6. PubMed ID: 19193505
    [Abstract] [Full Text] [Related]

  • 20. Testosterone patches in the management of patients with mild/moderate systemic lupus erythematosus.
    Gordon C, Wallace DJ, Shinada S, Kalunian KC, Forbess L, Braunstein GD, Weisman MH.
    Rheumatology (Oxford); 2008 Mar 20; 47(3):334-8. PubMed ID: 18238794
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.